Transmitter unit for a glucose monitoring skin patch
Latest Verily Life Sciences LLC Patents:
Description
The broken lines immediately adjacent the shaded areas represent the bounds of the claim, while all other broken lines are directed to environment; the broken lines form no part of the claimed design.
Claims
We claim the ornamental design for a transmitter unit for a glucose monitoring skin patch, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
9610031 | April 4, 2017 | Brister |
D794201 | August 8, 2017 | Newhouse |
20130267811 | October 10, 2013 | Pryor |
20140276576 | September 18, 2014 | Cole |
20150209508 | July 30, 2015 | Constantineau |
20160058380 | March 3, 2016 | Lee |
20160157759 | June 9, 2016 | Yang |
20160287150 | October 6, 2016 | Yu |
20170112534 | April 27, 2017 | Schoonmaker |
20170188912 | July 6, 2017 | Halac |
- Bergan, Mark et al., “Dexcom Has a Big Ally if Apple Gets Into Its Corner of the Diabetes Market”, Bloomberg News, Apr. 19, 2017, Retrieved from the internet: https://www.bloomberg.com/news/articles/2017-04-19/dexcom-has-a-big-ally-if-apple-gets-into-its-corner-of-the-diabetes-market, 5 pages.
Patent History
Patent number: D816229
Type: Grant
Filed: Aug 25, 2017
Date of Patent: Apr 24, 2018
Assignee: Verily Life Sciences LLC (Mountain View, CA)
Inventors: Sean Frick (San Francisco, CA), Matthew D. Day (Oakland, CA), Maaike L. Evers (San Francisco, CA), Shannon C. Fong (San Francisco, CA), Arthur Lin (Fremont, CA)
Primary Examiner: Anhdao Doan
Application Number: 29/615,071
Type: Grant
Filed: Aug 25, 2017
Date of Patent: Apr 24, 2018
Assignee: Verily Life Sciences LLC (Mountain View, CA)
Inventors: Sean Frick (San Francisco, CA), Matthew D. Day (Oakland, CA), Maaike L. Evers (San Francisco, CA), Shannon C. Fong (San Francisco, CA), Arthur Lin (Fremont, CA)
Primary Examiner: Anhdao Doan
Application Number: 29/615,071
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)